查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1970855

非侵入性脑损伤监测设备市场－全球产业规模、份额、趋势、机会、预测：按产品、最终用途、地区和竞争对手划分，2021-2031年

Non-invasive Brain Trauma Monitoring Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By End-use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

全球非侵入性脑损伤监测设备市场预计将从 2025 年的 149.3 亿美元大幅成长至 2031 年的 240.4 亿美元，复合年增长率为 8.26%。

这些专用医疗设备旨在评估颅内压、脑血流量和脑电活动等关键参数，无需手术切口或植入侵入性感测器。市场成长的主要驱动力是全球范围内由跌倒、车祸和运动相关衝击导致的创伤性脑损伤 (TBI) 病例的增加。所有这些都需要安全快速的诊断解决方案。这些事件的高发生率凸显了这种迫切性。根据美国脑损伤协会的数据，到 2025 年，美国约有十分之四的成年人会在头部受伤后出现与脑损伤相关的症状。

市场概览
预测期 2027-2031
市场规模：2025年 149.3亿美元
市场规模：2031年 240.4亿美元
复合年增长率：2026-2031年 8.26%
成长最快的细分市场 医院
最大的市场 北美洲

儘管市场前景广阔，但仍面临一个重大障碍：围绕非侵入式系统与侵入式黄金标准相比的准确性和可靠性的争论。神经外科医生和重症监护医生在仅依赖非侵入式数据做出影响患者生死的重要临床决策时往往十分谨慎，因为生理变异会影响感测器的准确性。因此，这些对测量准确性的担忧阻碍了监管部门的核准，并限制了医院将这些技术应用于日常患者照护的速度。

市场驱动因素

全球创伤性脑损伤 (TBI) 发生率的不断上升是推动非侵入性脑损伤监测设备市场发展的主要因素。随着车祸、跌倒等高衝击性事件的日益频繁，人们迫切需要能够即时进行诊断的手段，而这些手段无法透过需要在无菌手术环境下进行的侵入性方法来实现。这种需求促使人们寻求能够在急诊室和院前环境中快速部署的表面监测工具，从而加速早期医疗干预。美国疾病管制与预防中心 (CDC) 2024 年 1 月的监测报告进一步印证了这种紧迫性，该报告显示，美国每年有超过 69,000 人死于与 TBI 相关的疾病。这凸显了能够独立于神经外科基础设施运作的分流工具的重要性。

此外，携带式和穿戴式监测系统的技术进步正在拓展脑部监测的效用，使其不再局限于传统的加护病房（ICU），从而推动市场成长。近红外线光谱（NIRS）和脑电图（EEG）技术的创新使得设备体积更小，能够在临床环境中对颅内压和脑电活动进行连续、直接的评估。这项发展使得在救护车和运动诊所等场所进行即时数据收集成为可能，有效克服了固定式侵入性设备的限制。 Ceribell公司于2024年9月提交的一份报告便是这种快速临床应用的一个典型例证，该报告指出，其人工智慧驱动的携带式脑电图系统已评估了超过10万名患者。人口趋势也进一步推动了这一成长。根据世界卫生组织（WHO）2024年的报告，全球每年约有3730万人因跌倒需要医疗干预，这为这些用途广泛、非侵入性的解决方案提供了稳定的患者来源。

市场挑战

全球无创脑损伤监测市场发展面临的主要障碍之一是神经外科医师对非侵入性方法与侵入性颅内压监测相比的准确性和可靠性持续持怀疑态度。在重症监护环境中，绝对准确性至关重要，而非侵入性技术由于易受生理因素（例如头皮水肿和颅骨厚度变化）的信号干扰，往往需要经过严格的检验。这种技术上的不确定性迫使医务人员在生死攸关的决策中依赖现有的有创方法，从而极大地限制了非侵入性替代方案在急诊和加护病房的临床应用。

因此，这种信心的不足导致监管核准流程和医院采购週期双双放缓，阻碍了市场充分满足对便捷的创伤性脑损伤（TBI）管理工具的迫切经济需求。治疗不足造成的经济损失十分严重，这使得那些未经实验验证的技术检验市场认可。根据美国外科医师学会估计，到2024年，全球创伤性脑损伤造成的经济负担将高达每年4,000亿美元。在非侵入性设备能够被证实达到黄金标准的准确性之前，这种临床上的犹豫不决将继续限制其收入潜力和市场份额。

市场趋势

人工智慧 (AI) 在预测分析领域的应用正在改变市场格局，使设备从被动监测工具转变为主动、即时的临床决策支援系统。製造商正加速将机器学习演算法整合到非侵入式平台中，以便在出现身体症状之前识别细微的神经模式并绘製大脑功能图。这项进步对于在复杂的医疗环境中实现主动决策至关重要，并将技术从简单的观察转变为先进的诊断指导。 News-Medical.net 在 2025 年 6 月的一篇新闻报道便是监管和技术进步的一个鲜明例证。该报告指出，Sora 食品药物管理局的人工智慧驱动软体 Cirrus 已获得 FDA核准，该软体能够以非侵入式方式识别功能性脑部网路。

同时，专注于运动专案脑震盪管理解决方案的趋势正在形成一个独特的细分市场，其驱动力来自预防性医疗保健目标和职业运动的需求。设备开发商和体育联盟正优先采用能够追踪头部撞击暴露情况的技术，并透过改进设备和更严格的规则执行来降低受伤率，从而创建一种不同于紧急创伤监测的护理模式。这一趋势正在取得切实的安全成效。根据美国国家橄榄球联盟（NFL）2025年2月发布的报告，NFL橄榄球运营部门报告称，与上赛季相比，联盟内确诊的脑震盪病例减少了17%。这项突破性成就归功于数据驱动通讯协定和先进安全技术的广泛应用。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球非侵入性脑损伤监测设备市场展望

  • 市场规模及预测
    • 按金额
  • 市占率及预测
    • 产品分解（监控设备、耗材）
    • 透过申请（医院、神经科中心、其他）
    • 按地区
    • 按公司（2025 年）
  • 市场地图

第六章：北美非侵入性脑损伤监测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 北美洲：国别分析
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲非侵入性脑损伤监测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 欧洲：国别分析
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙

第八章：亚太地区非侵入性脑损伤监测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 亚太地区：国别分析
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲

第九章：中东和非洲非侵入性脑损伤监测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 中东与非洲：国别分析
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非

第十章：南美洲非侵入性脑损伤监测设备市场展望

  • 市场规模及预测
  • 市占率及预测
  • 南美洲：国别分析
    • 巴西
    • 哥伦比亚
    • 阿根廷

第十一章 市场动态

  • 促进因素
  • 任务

第十二章 市场趋势与发展

  • 併购
  • 产品发布
  • 近期趋势

第十三章：全球非侵入性脑损伤监测设备市场：SWOT分析

第十四章：波特五力分析

  • 产业竞争
  • 新进入者的潜力
  • 供应商的议价能力
  • 顾客权力
  • 替代品的威胁

第十五章 竞争格局

  • Advanced Brain Monitoring, Inc.
  • Cadwell Industries, Inc.
  • Canon Medical Systems Corporation
  • Compumedics Limited
  • Magstim, Inc
  • General Electric Company
  • Hitachi, Ltd.
  • Koninklijke Philips NV
  • Medtronic Plc
  • Siemens Healthineers AG

第十六章 策略建议

第十七章：关于研究公司及免责声明

简介目录
Product Code: 25348

The Global Non-invasive Brain Trauma Monitoring Devices Market is projected to expand significantly, rising from a valuation of USD 14.93 Billion in 2025 to USD 24.04 Billion by 2031, reflecting a compound annual growth rate of 8.26%. These specialized medical instruments are engineered to assess critical parameters such as intracranial pressure, cerebral blood flow, and electrical activity without the need for surgical incisions or invasive sensor placement. The market's momentum is largely propelled by the escalating global prevalence of traumatic brain injuries (TBIs) stemming from falls, vehicular collisions, and sports-related impacts, all of which demand safe and immediate diagnostic solutions. This urgent need is highlighted by the high incidence of such events; data from the Brain Injury Association of America indicates that in 2025, approximately four out of ten adults in the United States reported experiencing symptoms associated with brain injuries following head trauma.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 14.93 Billion
Market Size 2031USD 24.04 Billion
CAGR 2026-20318.26%
Fastest Growing SegmentHospitals
Largest MarketNorth America

Despite these growth prospects, the market faces a substantial obstacle regarding the debate over the accuracy and reliability of non-invasive systems when compared to the invasive gold standard. Neurosurgeons and critical care specialists frequently exercise caution before depending exclusively on non-invasive data for life-altering clinical decisions, as physiological variations can compromise sensor precision. Consequently, these concerns about measurement fidelity impede regulatory approvals and limit the rate at which hospitals adopt these technologies for routine patient care.

Market Driver

The escalating global incidence of traumatic brain injuries acts as a primary engine for the growth of the non-invasive brain trauma monitoring devices market. As high-impact events like automobile accidents and falls become more frequent, there is an imperative need for immediate diagnostic capabilities that invasive methods, which require sterile surgical environments, cannot offer. This necessity drives the demand for surface-based monitoring tools capable of rapid deployment in emergency rooms and pre-hospital scenarios to support early medical intervention. The urgency is underscored by data from the Centers for Disease Control and Prevention's January 2024 surveillance report, which notes that there are over 69,000 TBI-related deaths annually in the United States, highlighting the critical need for triage tools capable of operating independently from neurosurgical infrastructure.

Furthermore, technological breakthroughs in portable and wearable monitoring systems are catalyzing market expansion by extending the utility of brain monitoring beyond traditional intensive care units. Innovations in near-infrared spectroscopy and electroencephalography have led to device miniaturization, enabling continuous assessment of intracranial pressure and electrical activity directly at the point of care. This evolution allows for real-time data acquisition in ambulances and sports clinics, effectively overcoming the constraints of stationary, invasive equipment. A testament to this rapid clinical uptake is found in Ceribell, Inc.'s September 2024 filing, which reported that their portable AI-powered EEG system has assessed over 100,000 patients. This adoption is further driven by demographic trends; the World Health Organization reported in 2024 that approximately 37.3 million falls requiring medical attention occur globally each year, ensuring a steady stream of patients for these versatile non-invasive solutions.

Market Challenge

A major hurdle hindering the progress of the Global Non-invasive Brain Trauma Monitoring Devices Market is the enduring skepticism among neurosurgeons regarding the precision and reliability of these devices relative to invasive intracranial pressure monitoring. Because critical care demands absolute accuracy, non-invasive technologies often face scrutiny due to signal interference arising from physiological factors like scalp edema and varying skull thickness. This technical uncertainty compels medical professionals to rely on established invasive procedures for life-critical decisions, thereby significantly restricting the clinical uptake of non-invasive alternatives within emergency settings and intensive care units.

As a result, this lack of confidence decelerates both regulatory approval processes and hospital procurement cycles, preventing the market from fully addressing the urgent economic necessity for accessible TBI management tools. The financial implications of inadequate treatment are severe, creating high barriers for technologies viewed as experimentally unproven. According to the American College of Surgeons, the global economic burden of traumatic brain injury was estimated at $400 billion annually in 2024. Until non-invasive devices can convincingly demonstrate fidelity comparable to the gold standard, this clinical hesitation will continue to constrain their revenue potential and market share.

Market Trends

The integration of Artificial Intelligence for predictive analytics is transforming the market by elevating devices from passive monitoring tools to active, real-time clinical decision support systems. Manufacturers are increasingly incorporating machine learning algorithms into non-invasive platforms to identify subtle neurological patterns and map brain function prior to the onset of physical deterioration symptoms. This advancement is vital for enabling proactive decision-making in complex care environments, transitioning the technology from simple observation to advanced diagnostic guidance. A clear indication of this regulatory and technological progress is highlighted by News-Medical.net in June 2025, which reported that Sora Neuroscience received FDA clearance for its AI-driven Cirrus software to non-invasively identify functional brain networks.

Concurrently, a specialized focus on sports-specific concussion management solutions is carving out a distinct market segment driven by preventative health goals and professional athletic mandates. Device developers and sports leagues are prioritizing technologies that track head impact exposure and mitigate injury rates through enhanced equipment and strict rule enforcement, creating a care model separate from emergency trauma monitoring. This trend is delivering tangible safety outcomes; according to a February 2025 report by NFL Football Operations, the league observed a 17% reduction in diagnosed concussions compared to the previous season, a milestone credited to the widespread implementation of data-driven protocols and advanced safety technologies.

Key Market Players

  • Advanced Brain Monitoring, Inc.
  • Cadwell Industries, Inc.
  • Canon Medical Systems Corporation
  • Compumedics Limited
  • Magstim, Inc
  • General Electric Company
  • Hitachi, Ltd.
  • Koninklijke Philips N.V.
  • Medtronic Plc
  • Siemens Healthineers AG

Report Scope

In this report, the Global Non-invasive Brain Trauma Monitoring Devices Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Non-invasive Brain Trauma Monitoring Devices Market, By Product

  • Monitoring Devices
  • Consumables

Non-invasive Brain Trauma Monitoring Devices Market, By End-use

  • Hospitals
  • Neurological Centres
  • Others

Non-invasive Brain Trauma Monitoring Devices Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Non-invasive Brain Trauma Monitoring Devices Market.

Available Customizations:

Global Non-invasive Brain Trauma Monitoring Devices Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Monitoring Devices, Consumables)
    • 5.2.2. By End-use (Hospitals, Neurological Centres, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2025)
  • 5.3. Market Map

6. North America Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By End-use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By End-use
    • 6.3.2. Canada Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By End-use
    • 6.3.3. Mexico Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By End-use

7. Europe Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By End-use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By End-use
    • 7.3.2. France Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By End-use
    • 7.3.3. United Kingdom Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By End-use
    • 7.3.4. Italy Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By End-use
    • 7.3.5. Spain Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By End-use

8. Asia Pacific Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By End-use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By End-use
    • 8.3.2. India Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By End-use
    • 8.3.3. Japan Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By End-use
    • 8.3.4. South Korea Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By End-use
    • 8.3.5. Australia Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By End-use

9. Middle East & Africa Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By End-use
    • 9.2.3. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By End-use
    • 9.3.2. UAE Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By End-use
    • 9.3.3. South Africa Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By End-use

10. South America Non-invasive Brain Trauma Monitoring Devices Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By End-use
    • 10.2.3. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By End-use
    • 10.3.2. Colombia Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By End-use
    • 10.3.3. Argentina Non-invasive Brain Trauma Monitoring Devices Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By End-use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Non-invasive Brain Trauma Monitoring Devices Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Advanced Brain Monitoring, Inc.
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cadwell Industries, Inc.
  • 15.3. Canon Medical Systems Corporation
  • 15.4. Compumedics Limited
  • 15.5. Magstim, Inc
  • 15.6. General Electric Company
  • 15.7. Hitachi, Ltd.
  • 15.8. Koninklijke Philips N.V.
  • 15.9. Medtronic Plc
  • 15.10. Siemens Healthineers AG

16. Strategic Recommendations

17. About Us & Disclaimer